White House & Policy - April 02, 2026 (EOD)

 ## Policy Recap The administration took decisive action today by announcing new tariffs and executive orders that directly impacted several sectors. Notably, the president imposed a 100% tariff on certain patented pharmaceuticals, a move that signals a tough stance on drug pricing and trade policy. This tariff imposition is part of a broader effort to control healthcare costs and protect domestic pharmaceutical manufacturing. Additionally, the administration adjusted steel and aluminum tariff rates for derivative products, reflecting ongoing recalibrations in trade policy aimed at balancing domestic industry support with international trade relations. Congressional activity also influenced market sentiment as lawmakers advanced a deal to fund the Department of Homeland Security, including the Transportation Security Administration, averting a potential shutdown. This legislative progress provided some relief amid heightened geopolitical tensions. However, the president’s renewed threats to escalate military action in Iran and the announcement of a new timeline for strikes injected uncertainty into the market, overshadowing some of the positive legislative developments. Throughout the session, markets digested these policy developments with a cautious tone. The tariff announcements and Iran-related military threats created a risk-off environment early in the day, but some sectors found support from the administration’s infrastructure and defense spending priorities. The interplay between hawkish foreign policy signals and domestic trade measures kept investors on edge, resulting in mixed market outcomes. ## Market Reaction The broad market showed resilience despite the policy jitters. The S&P 500 (SPY) closed marginally higher by 0.08%, while the Nasdaq 100 (QQQ) was essentially flat, up 0.01%. The Dow Jones Industrial Average (DIA) edged down slightly by 0.10%, reflecting some profit-taking in industrials and healthcare. The Russell 2000 (IWM), a small-cap proxy, outperformed with a 0.59% gain, suggesting that domestic-focused stocks were less affected by international trade concerns. Bond markets reacted to the geopolitical and tariff news with a modest rally in long-duration Treasuries. The 20+ Year Treasury ETF (TLT) rose 0.52%, indicating a flight to safety amid uncertainty over the Iran conflict and tariff impacts. The U.S. dollar index (UUP) also gained 0.47%, supported by safe-haven demand and expectations of sustained Federal Reserve policy amid inflation concerns exacerbated by energy price shocks. Intraday swings were notable around the president’s speech threatening to escalate Iran strikes. Oil prices surged dramatically, with the United States Oil Fund (USO) jumping 11.98% to $138.96, reflecting fears of supply disruptions. This spike in energy prices contributed to volatility in equities, particularly in energy and industrial sectors. Overall, risk sentiment shifted toward caution, with investors balancing geopolitical risk against solid corporate earnings and infrastructure spending prospects. ## Sector Scorecard - **Financials (XLF):** Up 0.30%, financials benefited from the DHS funding deal and stable economic outlook despite geopolitical tensions. Banks and insurers showed modest gains as bond yields stabilized. - **Energy (XLE):** Led the sector gains with a 0.56% rise, driven by soaring oil prices amid Iran war escalation fears. Energy companies with upstream exposure, such as Devon Energy (DVN +1.98%) and Coterra Energy, saw positive momentum. - **Industrials (XLI):** Declined 0.47%, pressured by concerns over supply chain disruptions and potential tariff impacts on steel and aluminum derivatives. Defense contractors showed mixed performance amid increased defense spending expectations. - **Technology (XLK):** Rose 0.64%, supported by strong earnings and AI-related optimism. Despite broader market caution, tech stocks like Microsoft and Intel outperformed, reflecting resilience to geopolitical risks. - **Healthcare (XLV):** Fell 0.62%, weighed down by the new pharmaceutical tariffs and regulatory uncertainties. Large-cap pharma names like Amgen (AMGN -1.61%) and Biogen (BIIB -3.50%) underperformed as investors digested tariff implications. ## Winners & Losers ### Today's Policy Winners - **$AIRS** +14.29% - Benefited from increased interest in healthcare innovation amid tariff-driven sector volatility. - **$ASTS** +9.77% - Aerospace and space-related stocks surged on defense spending optimism linked to geopolitical tensions. - **$BKTI** +10.13% - Defense technology firm rallied on expectations of increased government contracts amid Iran conflict. - **$HES** +8.65% - Hess Corporation gained on rising oil prices fueled by supply concerns from Middle East instability. - **$LITE** +8.02% - Technology hardware firm rallied on AI demand and positive market sentiment despite broader risks. ### Today's Policy Losers - **$ANGO** -12.90% - Hit hard by tariff concerns and supply chain fears in industrial equipment. - **$FTLF** -12.31% - Consumer discretionary name impacted by tariff uncertainty and cautious consumer spending outlook. - **$LNN** -12.06% - Industrial supplier suffered from tariff adjustments and geopolitical risk affecting manufacturing. - **$AYI** -7.52% - Home improvement retailer declined amid tariff-driven cost pressures and cautious consumer sentiment. - **$SNAP** -5.51% - Social media stock declined on risk-off sentiment and sector rotation away from growth. ## Trade & Tariff Update The administration’s announcement of 100% tariffs on patented pharmaceuticals and adjustments to steel and aluminum derivative tariffs dominated trade-related market moves. Pharmaceutical companies faced immediate pressure, with sector ETF XLV down 0.62% and individual stocks like Amgen (-1.61%) and Biogen (-3.50%) reflecting tariff concerns. The tariff move is expected to raise costs for importers and potentially disrupt global supply chains. Industrial stocks sensitive to steel and aluminum tariffs, such as Lindsay Corporation (LNN -12.06%) and AngioDynamics (ANGO -12.90%), saw sharp declines. These tariff adjustments are part of a broader recalibration of trade policy aimed at protecting domestic producers but have raised concerns about cost inflation and supply chain bottlenecks. On the positive side, energy and defense-related firms benefited from the geopolitical backdrop and tariff-driven supply constraints. The surge in oil prices to over $140 per barrel supported energy stocks, while defense contractors anticipated increased government spending amid Iran conflict escalation. ## Tomorrow's Policy Calendar - Congressional committee votes expected on additional funding measures for homeland security and defense. - Pending executive orders on trade enforcement and tariff reviews may be announced. - Treasury Secretary scheduled to speak on inflation and trade policy outlook. - Senate hearing on the impact of tariffs on pharmaceutical innovation and healthcare costs. - Key risk factors include potential escalation in Iran conflict and further tariff expansions affecting global trade flows.